Isolated CD133+ subpopulations of HCC cells and xenograft mouse models confer increased chemoresistance to doxorubicin (DOX) and fluorouracil (5-FU) through activation of Akt/PKB and Bcl-2 survival pathways [27]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.